Role of ancillary techniques in diagnosing and subclassifying non‐Hodgkin's lymphomas on fine needle aspiration cytology
Author:
- 8 September 2006
- journal article
- review article
- Published by Wiley in Cytopathology
- Vol. 17 (5) , 275-287
Abstract
Non‐Hodgkin's lymphomas (NHL) are tumours of the lymphoid cells. During the process of development of lymphoid cells, neoplasia may evolve at any point. Neoplastic cells usually carry the imprint of cell of origin at the stage of origin. Various types of NHL may have similar morphology with wide variation in origin, immunophenotype and other biological features. Different ancillary laboratory techniques may help to overcome the limitations of morphology in this aspect. The commonly used ancillary techniques in lymphomas are immunocytochemistry (IC), flow cytometry, Southern blot (SB) technique, polymerase chain reaction (PCR) and fluorescent in situ hybridization (FISH). In addition, laser scanning cytometry (LSC) and DNA microarray technologies are in the research phase. Various laboratory techniques are used for immunophenotyping, demonstration of monoclonality, identification of chromosomal translocation, assessment of cell kinetics and expression of mRNA in the tumour cells. Flow cytometry helps in rapid immunophenotying of NHL and it has an added advantage over IC in recognizing the co‐expression of CD markers. Fine needle aspiration cytology (FNAC) combined with flow immunophenotyping may help us to diagnose and subclassify certain NHLs, such as follicular lymphoma and mantle cell lymphoma, which were previously recognized as pure morphological entities. Loss of morphology is one of the important limitations of flow cytometry. LSC can overcome this limitation by studying morphology along with the immunophenotyping pattern of individual cells. Chromosomal changes in NHL can be identified by SB, PCR and FISH. Molecular diagnosis of NHL helps in diagnosis, subclassification, prognostic assessment and even in planning of therapy. DNA microarray is a relatively newer and promising technology. It gives information about the expression of several thousands of genes in a tumour in a single experiment. In the near future, FNAC combined with ancillary techniques may play a major role in diagnosis, subclassification and management of lymphomas.Keywords
This publication has 80 references indexed in Scilit:
- Aneuploidy and malignancy: an unsolved equationJournal of Clinical Pathology, 2004
- Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-hodgkin lymphomaCancer, 2003
- Diagnosis of Natural Killer Cell Lymphoma by Cytology and Flow Cytometric ImmunophenotypingActa Cytologica, 2002
- Genomic Views of the Immune SystemAnnual Review of Immunology, 2000
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- T-Cell Receptor Gene Rearrangements as Clinical Markers of Human T-Cell LymphomasNew England Journal of Medicine, 1985
- Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1983
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982